Article info
Clinical and epidemiological research
Extended report
Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial
- Correspondence to Professor Xavier Chevalier, Department of Rheumatology, Henri Mondor Hospital, Creteil 94010, France; xavier.chevalier{at}hmn.aphp.fr
Citation
Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial
Publication history
- Received February 4, 2014
- Revised March 31, 2014
- Accepted April 13, 2014
- First published May 9, 2014.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions